3-(2-PyridylcarbaMoyl)benzeneboronic acid

3-(2-PyridylcarbaMoyl)benzeneboronic acid Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

[3-[(2-pyridinylamino)carbonyl]phenyl]boronic Acid is an impurity of Acalabrutinib (A115605), is an experimental anti-cancer drug and a selective Bruton''s tyrosine kinase (BTK) inhibitor. This kinase transmits signals from B-cell Receptor (BCR), and thus any genetic BTK mutation causes B-Cell immunodeficiency. Therefore, BTK inhibitors targeting B-cell signaling has shown great promise for the treatment of chronic lymphocytic leukemia (CLL).

3-(2-PyridylcarbaMoyl)benzeneboronic acid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

3-(2-PyridylcarbaMoyl)benzeneboronic acid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Alfa Aesar	400-6106006	saleschina@alfa-asia.com	China	30132	84
Yantai ShengKailun Chemical Technology Co., Ltd.	13356901049	3119594100@qq.com	China	8185	55
Bide Pharmatech Ltd.	400-1647117 15221909166	product02@bidepharm.com	China	63720	58
Bide Pharmatech Ltd.	400-6005915	sales@picasso-e.com	China	39668	58
Shanghai Jieshikai Biotechnology Co. , Ltd.	021-57520305 15221441005	fangrui@jskchem.com	China	49242	58

---

• 3-(2-PyridylcarbaMoyl)benzeneboronic acid, 97%
• (3-(pyridin-2-ylcarbamoyl) phenyl)boronic acidQ: What is (3-(pyridin-2-ylcarbamoyl) phenyl)boronic acid Q: What is the CAS Number of (3-(pyridin-2-ylcarbamoyl) phenyl)boronic acid
• Boronic acid, B-[3-[(2-pyridinylamino)carbonyl]phenyl]-
• (3-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid
• 874459-98-0